Eventide Balanced Fund Class N
ETNMX
NASDAQ- -
USD
- -
- -
- -
- -
(- -)
Recent
price
- -
P/E
ratio
- -
div
yld
- -
ROIC.AI
Capital Structure
FRC
•
in mil. unless spec.Working Capital
FRC
•
in mil. unless spec.Growth Rates
FRC
•
in mil. unless spec.Quarterly Revenue
FRC
•
in mil. unless spec.Quarterly Earnings Per Share
FRC
•
in mil. unless spec.Quarterly Dividends Per Share
FRC
•
in mil. unless spec.- Similar Companies
- Business
- Eventide Multi-Asset Income Fund Class N (ETNMX) is a diversified mutual fund managed by Eventide Asset Management LLC that seeks current income while maintaining the potential for capital appreciation through a balanced approach between fixed income and equity income securities. The fund invests across a broad universe of income-producing securities, including corporate bonds, mortgage-backed bonds, preferred stocks, dividend-paying stocks, real estate investment trusts (REITs), master limited partnerships (MLPs), Yieldcos, and option writing strategies; its portfolio typically allocates approximately 50% to US stocks, 44% to US bonds, with smaller exposures to non-US stocks, non-US bonds, cash, and other assets. Classified in the Morningstar Moderate Allocation category, ETNMX emphasizes companies that create value for stakeholders, aligning with Eventide's philosophy of investing that promotes human flourishing. Launched on July 15, 2015, and domiciled in the United States, the fund is available primarily to US investors with a minimum initial investment of $1,000 and features a net expense ratio of 1.02%. It is managed by David Dirk since inception and co-managed by Dolores Bamford since May 2019, with oversight from Eventide's investment team. Eventide Asset Management LLC, the fund's adviser, was founded in 2008 and is headquartered at One International Place, Suite 4210, Boston, Massachusetts; the firm oversees approximately $7 billion in assets under management across a range of mutual funds, ETFs, and private strategies focused on values-based investing. Recent developments at Eventide include the final close of the Eventide Healthcare Innovation Fund I, LP in May 2024 with $83 million in committed capital, marking the firm's first dedicated private investment vehicle targeting biotech innovations for underserved patient populations. In late 2025, Eventide expanded its systematic ETF lineup with the filing approval and planned December launch of the Eventide International ETF (ESIM), its inaugural ex-US focused fund using the Business 360® methodology. The firm also launched the Eventide US Market ETF (EUSM) earlier in 2025 and celebrated the one-year anniversary of the Eventide High Dividend ETF in October 2025, reflecting ongoing product diversification beyond traditional mutual funds like ETNMX.